If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Medical Affairs » Medical Affairs Excellence
Download FREE Excerpt
9 Info Graphics
17 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Medical Affairs has evolved into one of the most critical functions for the pharmaceutical sector. As its importance and duties have grown, Medical Affairs has faced many challenges in creating and maintaining the function as a global group.
Best Practices, LLC conducted this study to identify what companies require in order to create effective global capabilities for the Medical Affairs function. The study also reviews how companies are coordinating compliance standards across different geographies.
The benchmark data in this study will help companies find better ways to create successful global Medical Affairs organizations.
This study presents segmented responses by company size
Biotech; Pharmaceutical; Manufacturing; Consumer Products; Diagnostic; Medical Device; Health Care; Biopharmaceutical; Clinical Research; Laboratories
Amgen; Axon Pharma; Astellas; Insys Therapeutics; AstraZeneca; Xenoport; Baxter BioScience; Bayer; Biogen Idec; Boehringer Ingelheim; Eisai; Ipsen; Janssen; Jazz Pharmaceuticals; Eli Lilly; Lundbeck; Medunik; Merck; Merz Pharma; Onyx Pharmaceuticals; Purdue Pharma; Sanofi; Theravance; UCB Pharma; Upsher-Smith; ViiV Healthcare